Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: A randomized comparative trial

Indian Journal of Gastroenterology

Volumn 32, Issue 3, 2013, Pages 190-194

  Javid, Gul ^a   Zargar, Showkat Ali ^a   Bhat, Khurshid ^a   Khan, Bashir Ahmad ^a   Yatoo, Ghulam Nabi ^a   Gulzar, Ghulam Mohamad ^a   Shah, Altaf Hussain ^a   Sodhi, Jaswinder Singh ^a   Khan, Mushtaq Ahmad ^a   Shoukat, Abid ^a   Saif, Riyaz U ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antimicrobial resistance; Compliance; Peptic ulcer; Side effects

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PANTOPRAZOLE; TINIDAZOLE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METALLIC TASTE; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PEPTIC ULCER; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RAPID UREASE TEST; TASTE DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INCIDENCE; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; INDIA; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84878324409     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0304-7     Document Type: Article

References (32)

1. Graham DY, Adam E, Reddy GT, et al. Sero epidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991;36: 1084-8.
2. Graham DY, Yamaoka Y. Ethical considerations of comparing sequential and traditional anti-Helicobacter therapy. Ann Intern Med. 2007;147: 434-5.
3. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347: 1175-86.
4. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection a meta-analysis. Aliment Pharmacol Ther. 1999;13: 857-64.
5. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. Aliment Pharmacol Ther. 2001;15: 1023-9.
6. Bigard MA, Delchier JC, Riachi G, Thiabult P, Barthelemy P. One-week triple therapy using omeprazole, amoxicillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of Omeprazole and clarithromycin. Aliment Pharmacol Ther. 1998;12: 383-8.
7. Calvet X, Ducons J, Guardiola J, et al. One-week triple versus quadruple therapy for Helicobacter pylori infection-a randomized trial. Aliment Pharmacol Ther. 2002;16: 1261-7.
8. Deltenre M, Jonas C, van Gossum M, Buset M, Otero J, De Koster E. Omeprazole based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. Eur J Gastroenterol Hepatol. 1995;7 suppl 1: S39-44.
9. Vakil N. Helicobacter pylori eradication: sequential and traditional therapy. Gastroenterol Hepatol. 2009;3: 59-64.
10. Ramakrishan BS. Helicobacter pylori infection in India: the case against eradication. Indian J Gastroenterol. 2006;25: 25-7.
11. Thyagarajan SP, Ray P, Das BK, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicenteric study. J Gastroenterol Hepatol. 2003;18: 1373-8.
12. Datta S, Chattopadhyay S, Patra R, et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther. 2005;22: 51-7.
13. Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med. 2007;147: 553-62.
14. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut. 2007;56: 1353-7.
15. Zullo A, Hassan C, Morini S, et al. Sequential therapy for H. pylori an 'aberrant' therapy for general use. Dig Liver Dis. 2004;36: 852-3.
16. Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication. A randomized trial. Ann Intern Med. 2007;146: 556-63.
17. De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther. 2004;19: 407-14.
18. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000;14: 715-8.
19. De Francesco V, Zullo A, Hassan C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomized study. Dig Liver Dis. 2001;33: 676-9.
20. Newcombe RG, Altman DG. Proportion and their differences. In: Altman DG, Machin D, Trevor NB, Newcombe RG (eds). Statistics with Confidences, 2nd ed. London: BMJ Books; 2000. pp 45-56.
21. Kim YS, Kim SJ, Yoon JH, et al. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther. 2011;34: 1098-105.
22. Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Clin Ther. 2008;30: 528-34.
23. Park HG, Jung MK, Jung JT, et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. Aliment Pharmacol Ther. 2012;35: 56-65.
24. Laine L, Fennerty MB, Osato M, et al. Esomeprazole based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol. 2000;95: 3393-8.
25. Vakil N, Lanza F, Schwartz H, Barth J. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther. 2004;20: 99-107.
26. Greenberg ER, Anderson GL, Morgan DR, et al. 14-Day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011;378: 507-14.
27. Duck WM, Sobel J, Pruckler JM, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons. United States Emerg Infect Dis. 2004;10: 1088-94.
28. Thyagarajan SP, Ray P, Das BK, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol. 2003;18: 1373-8.
29. Bhatia V, Ahuja V, Das B, Bal C, Sharma MP. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. J Gastroenterol Hepatol. 2004;19: 619-25.
30. De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med. 2006;144: 94-100.
31. Castro Fernández M, Sánchez Muñoz D, García Díaz E, Galán Jurado MV, Rodríguez AC. Diagnosis of Helicobacter pylori infection using urease rapid test in patients with bleeding duodenal ulcer: influence of endoscopic signs and simultaneous corporal and antral biopsies. Rev Esp Enferm Dig. 2004;96: 599-602.
32. Archimandritis A, Tzivras M, Sougioultzis S, et al. Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non-variceal upper gastrointestinal bleeding. J Gastroenterol Hepatol. 2000;15: 369-73.